Erucic acid attenuates post-influenza secondary Staphylococcus aureus infection by modulating VCAM-1 and CEACAM-1 expression and gut dysbiosis
International Immunopharmacology · 2026
DOI: 10.1016/j.intimp.2026.116191 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026. Verfasst von Lifu Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou 511436, China. Hauptthemen laut MEDLINE: Vascular Cell Adhesion Molecule-1, Dysbiosis, Staphylococcus aureus, CEACAM1 Protein. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Secondary S. aureus infection following influenza is a critical complication with limited therapeutic options and leading to high mortality. This study investigates the potential application of erucic acid against post-influenza S. aureus infection. Our findings reveal that erucic acid demonstrated protective efficacy, as reduced lung index, weight loss, and relieved lung damage with post-influenza secondary S. aureus infection in mice. Erucic acid significantly inhibited the increase of S. aureus adhesion mediated by PR8 infection in vitro and in vivo. VCAM-1 and CEACAM-1 were identified as key adhesion molecules mediating erucic acid's anti-adhesive effects through RNA-seq, molecular docking, and molecular dynamics simulations. Immunohistochemistry, qPCR, and WB were performed to validate erucic acid's regulatory effect on VCAM-1 and CEACAM-1. Although both VCAM-1 and CEACAM-1 overexpression in mouse lungs promoted S. aureus adhesion, paradoxically, only VCAM-1 overexpression in vitro enhanced bacterial adhesion to BEAS-2B cells. Moreover, erucic acid treatment markedly attenuated this effect by suppressing VCAM-1 overexpression. 16S rRNA sequencing exhibited that erucic acid administration alleviates gut dysbiosis mediated by secondary S. aureus infection post-influenza. These findings reveal that erucic acid attenuated S. aureus adhesion by suppressing PR8-mediated upregulation of VCAM-1 and CEACAM-1. Furthermore, it mitigated pulmonary injury and gut dysbiosis induced by post-influenza secondary S. aureus infection. These findings are expected to offer novel therapeutic strategies for secondary S. aureus infection post-influenza.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou 511436, China.
- KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou 511436, China; Gansu Provincial Hospital of TCM, Lanzhou, Gansu 730050, China.
- Faculty of Chinese Medicine, Macau University of Science and Technology, Taipa, Macao, PR China; Department of Ultrasound Medicine, Liwan Central Hospital of Guangzhou, 35 Liwan Road, Guangzhou 510000, Guangdong, China.
- The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China.
- The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China. Electronic address: jeffyah@163.com.
- KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou 511436, China. Electronic address: kayleeleung@gzhmu.edu.cn.
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Liu, L., Gao, T., Liu, J., Zhao, J., Zhou, Y., Chen, Y., Pan, W., Deng, X., Yang, Z., & Liang, X. (2026). Erucic acid attenuates post-influenza secondary Staphylococcus aureus infection by modulating VCAM-1 and CEACAM-1 expression and gut dysbiosis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.116191
Vancouver
Liu L, Gao T, Liu J, Zhao J, Zhou Y, Chen Y, et al. Erucic acid attenuates post-influenza secondary Staphylococcus aureus infection by modulating VCAM-1 and CEACAM-1 expression and gut dysbiosis. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2026.116191
BibTeX
@article{Liu2026,
author = {Liu, Lifu and Gao, Taotao and Liu, Jinbing and Zhao, Jin and Zhou, Yingxuan and Chen, Yintong and Pan, Weiqi and Deng, Xiaoyan and Yang, Zifeng and Liang, Xiaoli},
title = {Erucic acid attenuates post-influenza secondary Staphylococcus aureus infection by modulating VCAM-1 and CEACAM-1 expression and gut dysbiosis},
journal = {International Immunopharmacology},
year = {2026},
doi = {10.1016/j.intimp.2026.116191}
}
EUVIMED